ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
5 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
4 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
19 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
23K
|
13M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Blackcat13
|
3.1K |
1.4M |
5 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Blackcat13
|
3.1K |
1.4M |
12 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
10 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Googala's 2020 Share Price Competitions
|
|
Blackcat13
|
303 |
102K |
9 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
303
|
102K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESOBLAST - GVHD - A BIRD IN THE HAND
|
|
Blackcat13
|
53 |
37K |
7 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
53
|
37K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
15 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
23K
|
13M
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
6 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Googala's 2020 Share Price Competitions
|
|
Blackcat13
|
303 |
102K |
1 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
303
|
102K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
2 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
4 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
|
|
Blackcat13
|
276 |
141K |
5 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
276
|
141K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Blackcat13
|
17K |
6.8M |
18 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
18
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
7 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
8 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
11 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
Blackcat13
|
311 |
166K |
28 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Gilead
|
|
Blackcat13
|
9 |
4.0K |
2 |
05/04/20 |
05/04/20 |
ASX - By Stock
|
9
|
4.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Gilead
|
|
Blackcat13
|
9 |
4.0K |
13 |
05/04/20 |
05/04/20 |
ASX - By Stock
|
9
|
4.0K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Blackcat13
|
443 |
199K |
12 |
15/03/20 |
15/03/20 |
ASX - By Stock
|
443
|
199K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
19 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
23K
|
13M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Blackcat13
|
4.4K |
2.4M |
12 |
19/01/20 |
19/01/20 |
ASX - By Stock
|
4.4K
|
2.4M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Blackcat13
|
23K |
13M |
5 |
08/01/20 |
08/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Blackcat13
|
4.4K |
2.4M |
9 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Blackcat13
|
4.4K |
2.4M |
2 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Blackcat13
|
4.4K |
2.4M |
10 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
10
|
|
ASX - By Stock
|
BCC |
Re:
Zoleo Potential - must read
|
|
Blackcat13
|
13 |
3.0K |
2 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
13
|
3.0K
|
2
|
|
ASX - By Stock
|
BCC |
Re:
Zoleo Potential - must read
|
|
Blackcat13
|
13 |
3.0K |
5 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
13
|
3.0K
|
5
|
|
ASX - By Stock
|
BCC |
Re:
Ann: Beam Communications Quarterly Investor Newsletter- June 2019
|
|
Blackcat13
|
6 |
2.2K |
0 |
26/06/19 |
26/06/19 |
ASX - By Stock
|
6
|
2.2K
|
0
|
|
ASX - By Stock
|
BCC |
Re:
Article in The Australia
|
|
Blackcat13
|
17 |
5.8K |
1 |
06/06/19 |
06/06/19 |
ASX - By Stock
|
17
|
5.8K
|
1
|
|
ASX - By Stock
|
BCC |
Re:
Ann: Market Update & Appendix 4C March Quarter 2019
|
|
Blackcat13
|
5 |
2.8K |
0 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Competition/ experiment..prediction of MSB price @ close of business June 28 2019
|
|
Blackcat13
|
135 |
54K |
2 |
09/04/19 |
09/04/19 |
ASX - By Stock
|
135
|
54K
|
2
|
|
ASX - By Stock
|
BCC |
Re:
Ann: Beam Enters Indian Satellite Market
|
|
Blackcat13
|
7 |
2.9K |
3 |
09/04/19 |
09/04/19 |
ASX - By Stock
|
7
|
2.9K
|
3
|
|